S. J. Zieman, Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.5, pp.932-975, 2005.
DOI : 10.1161/01.ATV.0000160548.78317.29

A. Benetos, Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications, American Journal of Hypertension, vol.15, issue.12, pp.1101-1109, 2002.
DOI : 10.1016/S0895-7061(02)03029-7

S. Laurent, Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients, Hypertension, vol.37, issue.5, pp.1236-1277, 2001.
DOI : 10.1161/01.HYP.37.5.1236

S. Meaume, Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Subjects >70 Years of Age, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.12, pp.2046-50, 2001.
DOI : 10.1161/hq1201.100226

L. Joly, Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.6, pp.979-85, 2009.
DOI : 10.1161/01.HYP.26.1.34

URL : https://hal.archives-ouvertes.fr/inserm-00616495

C. Vlachopoulos, Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals, Circulation, vol.112, issue.14, pp.2193-2200, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.535435

M. J. Roman, Arterial Stiffness in Chronic Inflammatory Diseases, Hypertension, vol.46, issue.1, pp.194-199, 2005.
DOI : 10.1161/01.HYP.0000168055.89955.db

R. H. Mackey, Calcifications, Arterial Stiffness and Atherosclerosis, Adv Cardiol, vol.44, pp.234-278, 2007.
DOI : 10.1159/000096744

P. Raggi, Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients, Kidney International, vol.71, issue.8, pp.802-809, 2007.
DOI : 10.1038/sj.ki.5002164

M. Safar, Vulnérabilité et vieillissement : comment les prévenir, les retarder ou les maîtriser ? ©, 2002.

S. Laurent, Expert consensus document on arterial stiffness: methodological issues and clinical applications, European Heart Journal, vol.27, issue.21, pp.2588-2605, 2006.
DOI : 10.1093/eurheartj/ehl254

URL : https://academic.oup.com/eurheartj/article-pdf/27/21/2588/9626329/ehl254.pdf

C. M. Mceniery, Normal Vascular Aging: Differential Effects on Wave Reflection and Aortic Pulse Wave Velocity, Journal of the American College of Cardiology, vol.46, issue.9, pp.1753-60, 2005.
DOI : 10.1016/j.jacc.2005.07.037

J. Blacher, Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive Patients, Hypertension, vol.33, issue.5, pp.1111-1118, 1999.
DOI : 10.1161/01.HYP.33.5.1111

K. Cruickshank, Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function?, Circulation, vol.106, issue.16, pp.2085-90, 2002.
DOI : 10.1161/01.CIR.0000033824.02722.F7

G. M. London, Arterial Wave Reflections and Survival in End-Stage Renal Failure, Hypertension, vol.38, issue.3, pp.434-442, 2001.
DOI : 10.1161/01.HYP.38.3.434

D. Behrendt, Endothelial function, The American Journal of Cardiology, vol.90, issue.10, pp.40-48, 2002.
DOI : 10.1016/S0002-9149(02)02963-6

P. E. Szmitko, New Markers of Inflammation and Endothelial Cell Activation: Part I, Circulation, vol.108, issue.16, pp.1917-1940, 2003.
DOI : 10.1161/01.CIR.0000089190.95415.9F

J. Belmin, Le vieillissement de la paroi art??rielle, m??decine/sciences, vol.9, issue.10, pp.1068-78, 1993.
DOI : 10.4267/10608/2810

R. M. Touyz, Oxidative stress and vascular damage in hypertension, Current Hypertension Reports, vol.3, issue.1, pp.98-105, 2000.
DOI : 10.1161/01.HYP.25.2.155

R. J. Gryglewski, Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature, vol.33, issue.6061, pp.454-460, 1986.
DOI : 10.1111/j.1476-5381.1964.tb01592.x

E. G. Lakatta, Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging, Circulation, vol.107, issue.3, pp.490-497, 2003.
DOI : 10.1161/01.CIR.0000048894.99865.02

M. Cecelja, Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension: A Systematic Review, Hypertension, vol.54, issue.6, pp.1328-1364, 2009.
DOI : 10.1161/HYPERTENSIONAHA.109.137653

A. Benetos, Determinants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period, Circulation, vol.105, issue.10, pp.1202-1209, 2002.
DOI : 10.1161/hc1002.105135

S. S. Franklin, Hemodynamic Patterns of Age-Related Changes in Blood Pressure : The Framingham Heart Study, Circulation, vol.96, issue.1, pp.308-323, 1997.
DOI : 10.1161/01.CIR.96.1.308

H. D. Sesso, C-Reactive Protein and the risk of developing hypertension, JAMA, vol.290, pp.3000-3002, 2003.

G. M. London, Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients, Kidney International, vol.63, pp.88-93, 2003.
DOI : 10.1046/j.1523-1755.63.s84.25.x

S. K. Venugopal, Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells, Circulation, vol.106, issue.12, pp.1439-1480, 2002.
DOI : 10.1161/01.CIR.0000033116.22237.F9

S. Verma, A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis, Circulation, vol.106, issue.8, pp.913-932, 2002.
DOI : 10.1161/01.CIR.0000029802.88087.5E

W. Chao-hung, C-reactive protein up-regulates angiotensin type 1 receptors in vascular smooth cells, Circulation, vol.107, pp.1783-90, 2003.

V. J. Dzau, Tissue Angiotensin and Pathobiology of Vascular Disease : A Unifying Hypothesis, Hypertension, vol.37, issue.4, pp.1047-52, 2001.
DOI : 10.1161/01.HYP.37.4.1047

M. Ruiz-ortega, Proinflammatory actions of angiotensins, Current Opinion in Nephrology and Hypertension, vol.10, issue.3, pp.321-330, 2001.
DOI : 10.1097/00041552-200105000-00005

R. M. Touyz, The role of angiotensin II in regulating vascular structural and functional changes in hypertension, Current Hypertension Reports, vol.359, issue.3, pp.155-64, 2003.
DOI : 10.1161/01.HYP.38.1.100

R. Kranzhofer, Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.7, pp.1623-1652, 1999.
DOI : 10.1161/01.ATV.19.7.1623

A. Broisat, Physiopathologie de la plaque d'athérome vulnérable. Médecine Nucléaire- Imagerie fonctionnelle et métabolique, pp.198-202, 2005.

H. C. Stary, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.89, issue.5, pp.2462-78, 1994.
DOI : 10.1161/01.CIR.89.5.2462

H. C. Stary, A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Special report. Circulation, vol.92, pp.1355-74, 1995.

P. Libby, Inflammation and Atherosclerosis, Circulation, vol.105, issue.9, pp.1135-1178, 2002.
DOI : 10.1161/hc0902.104353

C. H. Saely, High-dose statin therapy for high-risk patients, Herz, vol.120, issue.7, pp.497-502, 2010.
DOI : 10.1007/s00508-008-1010-9

A. R. Ahlgren, Increased aortic stiffness in women with Type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function, Diabetic Medicine, vol.16, issue.4, pp.291-298, 1999.
DOI : 10.1046/j.1464-5491.1999.00079.x

P. Tounian, Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study, The Lancet, vol.358, issue.9291, pp.1400-1404, 2001.
DOI : 10.1016/S0140-6736(01)06525-4

G. Nickenig, Insulin Induces Upregulation of Vascular AT1 Receptor Gene Expression by Posttranscriptional Mechanisms, Circulation, vol.98, issue.22, pp.2453-60, 1998.
DOI : 10.1161/01.CIR.98.22.2453

R. N. Foley, Clinical epidemiology of cardiovascular disease in chronic renal disease, American Journal of Kidney Diseases, vol.32, issue.5, pp.112-131, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9820470

J. Blacher, Impact of Aortic Stiffness on Survival in End-Stage Renal Disease, Circulation, vol.99, issue.18, pp.2434-2473, 1999.
DOI : 10.1161/01.CIR.99.18.2434

A. P. Guérin, Arterial structure and function in end-stage renal disease, Current Hypertension Reports, vol.45, issue.Part1, pp.107-118, 2008.
DOI : 10.1161/01.CIR.99.18.2434

A. P. Guérin, Arterial stiffening and vascular calcifications in end???stage renal disease, Nephrology Dialysis Transplantation, vol.15, issue.7, pp.1014-1035, 2000.
DOI : 10.1093/ndt/15.7.1014

G. M. London, Arteriosclerosis and arterial calcifications in chronic kidney insufficiency, Nephrol Ther, vol.1, pp.351-355, 2005.

N. X. Chen, Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells, Kidney International, vol.62, issue.5, pp.1724-1755, 2002.
DOI : 10.1046/j.1523-1755.2002.00625.x

S. Jono, Phosphate Regulation of Vascular Smooth Muscle Cell Calcification, Circulation Research, vol.87, issue.7, pp.10-17, 2000.
DOI : 10.1161/01.RES.87.7.e10

J. Braun, Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients, American Journal of Kidney Diseases, vol.27, issue.3, pp.394-401, 1996.
DOI : 10.1016/S0272-6386(96)90363-7

W. G. Goodman, Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis, New England Journal of Medicine, vol.342, issue.20, pp.1478-83, 2000.
DOI : 10.1056/NEJM200005183422003

M. Cesari, Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study, Circulation, vol.108, issue.19, pp.2317-2339, 2003.
DOI : 10.1161/01.CIR.0000097109.90783.FC

P. M. Ridker, Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men, New England Journal of Medicine, vol.336, issue.14, pp.973-79, 1997.
DOI : 10.1056/NEJM199704033361401

P. M. Ridker, Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events, New England Journal of Medicine, vol.347, issue.20, pp.1557-65, 2002.
DOI : 10.1056/NEJMoa021993

R. S. Robenson, High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease, Current Opinion in Cardiology, vol.17, issue.4, pp.325-356, 2002.
DOI : 10.1097/00001573-200207000-00001

G. J. Blake, High sensitivity C-reactive protein, potential adjunct for global risk assessment in the primary prevention of cardiovascular disease, Circulation, vol.103, pp.1813-1818, 2001.

M. C. Mceniery, C-reactive protein is associated with arterial stiffness in apparently healthy individuals, Arterioscler Thromb Vasc Biol, vol.24, pp.969-74, 2004.

S. Verma, Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein, Circulation, vol.105, issue.16, pp.1890-96, 2002.
DOI : 10.1161/01.CIR.0000015126.83143.B4

C. M. Mceniery, Aortic Calcification Is Associated With Aortic Stiffness and Isolated Systolic Hypertension in Healthy Individuals, Hypertension, vol.53, issue.3, pp.524-555, 2009.
DOI : 10.1161/HYPERTENSIONAHA.108.126615

N. X. Chen, Calcifications vasculaires dans l'insuffisance rénale. Flammarion Médecine- Sciences ? Actualités Néphrologiques, 2004.

M. Safar, Signification de la pression pulsée chez l'hypertendu. 'Cardiologiefrancophone .com/PDF/articles/recommandations-traitement-hypertension

A. Benetos, Pulse Pressure and Cardiovascular Mortality in Normotensive and Hypertensive Subjects, Hypertension, vol.32, issue.3, pp.560-564, 1998.
DOI : 10.1161/01.HYP.32.3.560

URL : http://hyper.ahajournals.org/content/hypertensionaha/32/3/560.full.pdf

S. Laurent, Abridged version of the expert consensus document on arterial stiffness, Artery Research, vol.1, issue.1, pp.2-12, 2007.
DOI : 10.1016/j.artres.2007.03.003

L. Joly, Pulse Wave Velocity Assessment by External Noninvasive Devices and Phase-Contrast Magnetic Resonance Imaging in the Obese, Hypertension, vol.54, issue.2, pp.421-447, 2009.
DOI : 10.1161/HYPERTENSIONAHA.109.133645

URL : https://hal.archives-ouvertes.fr/inserm-00617102

P. Salvi, Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity, Journal of Hypertension, vol.22, issue.12, pp.2285-93, 2004.
DOI : 10.1097/00004872-200412000-00010

P. Boutouyrie, Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors:'establishing normal and reference values, Eur Heart J, vol.31, pp.2338-50, 2010.

C. Alecu, Reference values of aortic pulse wave velocity in the elderly, Journal of Hypertension, vol.26, issue.11, pp.2207-2219, 2008.
DOI : 10.1097/HJH.0b013e32830e4932

M. Soret, G. Bonardel, E. Gontier, and H. Foehrenbach, Principe et technique de la tomographie d'émission de positons couplée à la tomodensitométrie. Encycl Méd Chir, Radiologie et imagerie médicale ? principes et technique ? radioprotection, 2011.
DOI : 10.1016/s1879-8497(10)72881-8

C. Comtat and . Cours-de-des-médecine-nucléaire, Instrumentation -Tomographie par émission de positons ? CEA de Saclay, 2010.

J. P. Vuilliez, Métabolisme glucidique des cellules tumorales : conséquences pour l'utilisation de radiopharmaceutiques analogues du glucose, Médecine Nucléaire, vol.22, pp.9-29, 1998.

J. Feuardent, Reliability of uptake estimates in FDG PET as a function of acquisition and processing protocols using the CPET, IEEE Transactions on Nuclear Science, vol.52, issue.5, pp.1447-52, 2005.
DOI : 10.1109/TNS.2005.858222

M. C. Adams, A Systematic Review of the Factors Affecting Accuracy of SUV Measurements, American Journal of Roentgenology, vol.195, issue.2, pp.310-330, 2010.
DOI : 10.2214/AJR.10.4923

H. H. Sung-cheng, Anatomy of SUV, Nucl Med Biol, vol.27, pp.643-689, 2000.

R. Kubota, Intra-tumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by micro-autoradiography, J Nucl Med, vol.33, pp.1972-80, 1992.

G. Helft, Non invasive in vivo imaging of atherosclerotic lesions with fluorine-18 deoxyglucose 18-FDG PET correlates with macrophage content in a rabbit model, Circulation, vol.18, pp.300-311, 1999.

DOI : 10.1097/00007890-199810270-00022

M. A. Walter, The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease, European Journal of Nuclear Medicine and Molecular Imaging, vol.43, issue.Suppl 2, pp.674-81, 2005.
DOI : 10.7326/0003-4819-122-7-199504010-00004

M. A. Walter, [18F]Fluorodeoxyglucose PET in Large Vessel Vasculitis, Radiologic Clinics of North America, vol.45, issue.4, pp.735-779, 2007.
DOI : 10.1016/j.rcl.2007.05.012

T. Belhocine, Imaging of large vessel vasculitis with 18 FDG PET: illusion or reality? A critical review of the literature data, European Journal of Nuclear Medicine and Molecular Imaging, vol.30, issue.9, pp.1305-1318, 2003.
DOI : 10.1007/s00259-003-1209-y

J. H. Rudd, 18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible, Journal of the American College of Cardiology, vol.50, issue.9, pp.892-96, 2007.
DOI : 10.1016/j.jacc.2007.05.024

J. H. Rudd, Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations, Journal of Nuclear Medicine, vol.49, issue.6, pp.871-78, 2008.
DOI : 10.2967/jnumed.107.050294

URL : http://jnm.snmjournals.org/content/49/6/871.full.pdf

G. S. Meirelles, 18F-FDG Uptake and Calcifications in the Thoracic Aorta on Positron Emission Tomography/Computed Tomography Examinations, Journal of Thoracic Imaging, vol.26, issue.1, pp.54-62, 2011.
DOI : 10.1097/RTI.0b013e3181d9c9f9

L. J. Menezes, What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque, Atherosclerosis, vol.211, issue.1, pp.136-176, 2010.
DOI : 10.1016/j.atherosclerosis.2010.01.012

S. Grandpierre, Arterial Foci of F-18 Fluorodeoxyglucose Are Associated With an Enhanced Risk of Subsequent Ischemic Stroke in Cancer Patients, Clinical Nuclear Medicine, vol.36, issue.2, pp.85-90, 2011.
DOI : 10.1097/RLU.0b013e318203bb42

R. M. Kwee, Identifying vulnerable carotid plaques by noninvasive imaging, Neurology, vol.70, issue.Issue 24, Part 2, pp.2401-2410, 2008.
DOI : 10.1212/01.wnl.0000314697.76580.cb

M. Tatsumi, Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis, Radiology, vol.229, issue.3, pp.831-838, 2003.
DOI : 10.1148/radiol.2293021168

J. A. Wassélius, FDG-Accumulating Atherosclerotic Plaques Identified with 18F-FDG-PET/CT in 141 Patients, Molecular Imaging and Biology, vol.49, issue.14, pp.455-464, 2009.
DOI : 10.1161/01.CIR.94.10.2662

B. Ibañez, Diagnosis of Atherosclerosis by Imaging, The American Journal of Medicine, vol.122, issue.1, pp.15-25, 2009.
DOI : 10.1016/j.amjmed.2008.10.014

S. Vallabhajosula, Imaging atherosclerotic lesions by positron emission tomography (PET) using F-18-fluorodeoxyglucose(FDG): preclinical studies in hypercholesterolemic rabbits, Circulation, vol.92, pp.313-319, 1995.

H. Kai, Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography, Geriatrics & Gerontology International, vol.15, issue.1, pp.1-8, 2010.
DOI : 10.1161/01.CIR.104.3.249

J. R. Davies, FDG???PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis, The International Journal of Cardiovascular Imaging, vol.47, issue.1, pp.41-49, 2010.
DOI : 10.1177/002215549904700113

G. G. Bural, Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept, Nuclear Medicine and Biology, vol.33, issue.8, pp.1037-1080, 2006.
DOI : 10.1016/j.nucmedbio.2006.08.005

G. G. Bural, FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.1, pp.562-571, 2008.
DOI : 10.1590/S1807-59322005000500011

K. Aziz, Noninvasive Detection and Localization of Vulnerable Plaque and Arterial Thrombosis With Computed Tomography Angiography/Positron Emission Tomography, Circulation, vol.117, issue.16, pp.2061-70, 2008.
DOI : 10.1161/CIRCULATIONAHA.106.652313

Y. W. Wu, Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1, J Nucl Med, vol.48, pp.227-260, 2007.

A. Rominger, 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease, Journal of Nuclear Medicine, vol.50, issue.10, pp.1611-1631, 2009.
DOI : 10.2967/jnumed.109.065151

T. Hayashida, PET Features of Aortic Diseases, American Journal of Roentgenology, vol.195, issue.1, pp.229-262, 2010.
DOI : 10.2214/AJR.09.3952

M. P. Dunphy, Association of vascular 18 F-FDG uptake with vascular calcification, J Nucl Med, vol.46, pp.1278-84, 2005.

S. J. Lee, Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction, Journal of Nuclear Medicine, vol.49, issue.8, pp.1277-82, 2008.
DOI : 10.2967/jnumed.108.052233

N. Tahara, Simvastatin Attenuates Plaque Inflammation, Journal of the American College of Cardiology, vol.48, issue.9, pp.1825-1856, 2006.
DOI : 10.1016/j.jacc.2006.03.069

URL : https://doi.org/10.1016/j.jacc.2006.03.069

P. P. Dimitrow, Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia, Pharmacological Reports, vol.62, issue.6, pp.1250-1254, 2010.
DOI : 10.1016/S1734-1140(10)70390-X

G. E. Pate, Anti-inflammatory Effects of Statins in Patients with Aortic Stenosis, Journal of Cardiovascular Pharmacology and Therapeutics, vol.10, issue.1, pp.201-207, 2003.
DOI : 10.1016/S0895-7061(97)00268-9

K. M. Mäki-petäjä, Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction, Current Pharmaceutical Design, vol.15, issue.3, pp.290-303, 2009.
DOI : 10.2174/138161209787354221

T. Nobuhiro, Simvastatin attenuates plaque inflammation :evaluation by fluorodeoxyglucose positron emission tomography, J Am Coll Cardiol, vol.48, pp.1825-1856, 2006.

M. Ogawa, Application of 18 F-FDG PET for monitoring the therapeutic effect of anti-inflammatory drugs on stabilization of vulnerable atherosclerotic plaques, J Nucl Med, vol.47, pp.1845-50, 2006.

J. H. Rudd, Inflammation Imaging in Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.7, pp.1009-1116, 2009.
DOI : 10.1161/ATVBAHA.108.165563

J. H. Rudd, Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study, Circulation: Cardiovascular Imaging, vol.2, issue.2, pp.107-115, 2009.
DOI : 10.1161/CIRCIMAGING.108.811752

J. H. Rudd, Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography, Circulation, vol.105, issue.23, pp.2708-2719, 2002.
DOI : 10.1161/01.CIR.0000020548.60110.76

URL : http://circ.ahajournals.org/content/circulationaha/105/23/2708.full.pdf

N. Tahara, Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose Positron Emission Tomography Is Associated With the Metabolic Syndrome, Journal of the American College of Cardiology, vol.49, issue.14, pp.1533-1572, 2007.
DOI : 10.1016/j.jacc.2006.11.046

T. N. Kim, Vascular Inflammation in Patients With Impaired Glucose Tolerance and Type 2 Diabetes: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography, Circulation: Cardiovascular Imaging, vol.3, issue.2
DOI : 10.1161/CIRCIMAGING.109.888909

R. Holman, The natural history of atherosclerosis : the early aortic lesions as seen in New Orleans in the middle of the 20 th Century, Am J Pathol, vol.34, pp.209-235, 1958.

R. Bos, Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography, Journal of Clinical Oncology, vol.20, issue.2, pp.379-87, 2002.
DOI : 10.1200/JCO.2002.20.2.379